Hillary Clinton All Bark, No Bite with Biotech Tweet
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Market Reaction to Clinton Proposals Seen as 'Premature' and 'Overdone' - TD Securities (VRX)
September 23, 2015 11:42 AM UTCTD Securities maintained a Buy rating on Valeant Pharmaceuticals (NYSE: VRX) with a price target of $300. Analyst Lennox Gibbs called the market's reaction to proposals from presidential candidate Hillary Clinton premature and overdone.
Gibbs views plans to authorize Medicare to negotiate prices with drug manufacturers as the most noteworthy of Clinton's proposals, and he pointed out that Valeant derives an estimated 1520% of its revenues from Medicare.
"Drug stocks are down 3% since... More
Hillary Clinton Tweet Doesn't Change Bullish View on Valeant Pharmaceuticals (VRX), BMO Capital Says
September 21, 2015 1:57 PM UTCBMO Capital analyst Alex Arfaei weighed in on Valeant Pharmaceuticals (NYSE: VRX) which is down 6% in response to a Tweet from Hillary Clinton referring to this article in the... More
UPDATE: Biotech Bounces Off Lows (IBB)
September 21, 2015 1:19 PM UTC(Updated - September 21, 2015 1:29 PM EDT)
Biotech stocks bounced off lows Monday afternoon, paring declines that were largely driven by fears of increased government regulation of drug pricing. The source of concern was a tweet by presidential candidate Hillary Clinton... More
